Comparative efficacy and safety of immune checkpoint inhibitor-related therapies for advanced melanoma: a Bayesian network analysis
Author(s) -
Xin Li,
Junpeng Wang,
Yun Yao,
Lei Yang,
Zhiqin Li,
Yu Cheng,
Peiyan Zhao,
Yongli Yu,
Liying Wang
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.18906
Subject(s) - ipilimumab , medicine , nivolumab , pembrolizumab , oncology , melanoma , clinical trial , immunotherapy , cancer , cancer research
We aimed to compare and rank the effects of 9 immune checkpoint inhibitor-related therapies for treating advanced melanoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom